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A 36-year-old man visited our hospital because of blurred vision and redness of the conjunctiva. Slit-lamp examination showed
panuveitis. Two days later, he suddenly experienced dizziness, speech disturbance, paralysis of his right extremities, and gait
disturbances. Neurological examinations suggested that his symptoms were caused by a left lateral medullary lesion. He also had
erythema mainly on his trunk. Magnetic resonance imaging (MRI) of his brain demonstrated a small infarct on the left side of
the medulla oblongata. Clinical presentation and MRI ﬁndings were consistent with the diagnosis of a Wallenberg’s syndrome. He
also had bilateral hilar lymphadenopathy. A skin biopsy showed granulomatous nodular dermatitis compatible with sarcoidosis.
He was treated with steroid pulse therapy and his neurological and ocular symptoms immediately improved. Only seven similar
cases of intracranical sarcoidosis have been reported, but none had been treated with steroid pulse therapy. We recommend that
steroid pulse therapy be considered to treat patients with sarcoidosis with signs of lesions in the central nervous system.
1.Introduction
Sarcoidosis is characterized by noncaseating granulomas,
and in 5% of the patients, the lesions are located in the
central nervous system [1]. However, strokes are uncommon
in patients with sarcoidosis in spite of small vessel inﬂam-
mation, and sarcoidosis in the medulla oblongata is rare [2–
4]. Sarcoidosis is a systemic disease associated with uveitis
and accounts for 10% of the uveitis cases in Japan [5, 6].
Ocularsarcoidosisismanagedwellbysystemiccorticosteroid
therapy and is generally easier to manage than eyes with
Bechet disease [7].
Chronic posterior ocular sarcoidosis is more diﬃcult to
manage, and it can lead to sight-threatening complications,
for example, cataracts, glaucoma, and cystoid macular
oedema. Eyes with posterior uveitis with chronic sarcoidosis
have a poor visual prognosis despite immunosuppressive
therapy [8].
Corticosteroids, usually combined with immnosuppre-
sive agents, remain the mainstay therapy for ocular sarcoido-
sis although refractory cases do occur [9]. The refractory
cases generally have a poor visual prognosis.
We described a patient with ocular sarcoidosis and a
cerebral infarction, who had an excellent response to steroid-
pulse therapy.
2.CaseReport
A 36-year-old man reported blurred vision and redness of
the conjunctiva in both eyes. He was referred to our hospital
in January 2009, and our examination showed that his best-
corrected visual acuity (BCVA) was 1.2 (20/20) in both eyes.
Slit-lamp examination showed ciliary injection and keratic
precipitates. Fundus examination demonstrated vasculitis in
both eyes (Figures 1(a) and 1(b)).
Physical examination showed exudative erythema nodo-
sum on his trunk and both thighs. Chest X-rays and CT
scans demonstrated bilateral hilar and mediastinal lymph
node swelling. Laboratory tests, including antibodies for
rheumatoid factor, Sj¨ ogren syndrome, double-stranded
DNA, and antinuclear antibodies, were negative. In addition,
the serum antiotensin-converting enzyme level was high at
27.0 U/L (normal <20).2 Case Reports in Medicine
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Figure 1: Composite photographs of the fundus and ﬂuorescein angiograms of a patient with ocular sarcoidosis with an infarct in the
medulla oblongata. (a) and (b) Inﬁltrates and ischemic areas can be seen. (c) and (d) Fluorescein angiograms of right and left eyes showing
areas of nonperfusion (arrow) in both eyes.
Two days after his ﬁrst visit, he reported dizziness, speech
disturbance, clumsiness of his right extremities, and gait
disturbances. Neurological examinations showed left ptosis
and miosis, hoarseness, dysphagia, right mild hemiparesis,
left ataxia of his extremities, and truncal ataxia. He also had
hypalgesia/hypotemperatureonhisrightside.Theseﬁndings
suggested a left Wallenberg syndrome. Brain magnetic reso-
nanceimaging(MRI)showedaninfarctontheleftsideofthe
medullaoblongata(Figure 2).Leptomeningealenhancement
was not observed on MRI. Studies of the cerebrospinal ﬂuid
showed normal glycorrhachia (74mg/dL), mild lymphocyte
elevation, and elevated protein at 69mg/dL. These ﬁndings
suggested inﬂammatory processes in the central nervous
systems. Dermal examination/skin biopsy revealed granulo-
matous nodular dermatitis (Figure 3). 18F-FDG in the acute
stage showed an upregulation of both hillar lymphadenitis in
the mediastinum and ocular regions.
The patient was diagnosed with neurosarcoidosis with
a brainstem infarct. Steroid pulse therapy was prescribed
initially with 1000mg infusion for three days and then slowly
tapered. During the pulse therapy, the patient had laser
photocoagulation of the nonperfused areas of the retina.
The patient had an improvement of his symptoms after the
steroid-pulse therapy.
AtthelastexaminationonFebruary2011,thepatientwas
stable with no complications and no recurrence of the ocular
and CNS sarcoidosis. And his BCVA was 20/20.
3. Discussion
Our ﬁndings showed that our patient had CNS sarcoidosis
of the medulla oblongata, and steroid-pulse therapy was very
eﬀective in resolving the symptoms. The mechanism causing
the brain infarction in neurosarcoidosis is not completely
known but is thought to result from vasculitis of the small
vessels, emboli, or inﬂammation of the large vessels [16, 17].
Granulomatous invasion into the blood vessel walls with
disruption of the media and internal elastic laminae can
cause infarctions of small vessels [18].
Although rare, neurosarcoidosis should be considered
in cases of an acute stroke with restricted diﬀusion of
unknown etiology in a young person, even if other stigmata
of sarcoidosis are not present. Despite the common ﬁnding
ofvasculitisandmicroscopic infarctionatautopsy, astrokeis
usually due to vascular accidents in the cerebral hemisphere
andisrarelythepresentingsignofneurosarcoidosis(Table 1)
[10,11,15].TherarityofbrainstemstrokeissurprisinggivenCase Reports in Medicine 3
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Figure 2: Images of the brain of a patient with an infarct in the medulla oblongata. (a) Left medulla oblongata encephalomalacia on axial
T2-ﬂuid-attenuated inversion image (arrow head). (b) Diﬀusion-weighted (TTt) image showing restricted diﬀusion in the left medulla
oblongata (arrowhead).
Table 1: Past reports which reported CNS sarcoidosis as brain ischemic stroke.
Location Eye symptom
Navi, 2009 [10] 35M Pons None
46F Pons None
Hodge, 2007 [11] 36f Left frontal subcortical white matter None
Brisman, 2006 [12] 41m Frontal and lobe Left eye blindness
Nakagaki, 2004 [13] 75m Right parieto occipital lobes Ocular sarcoidosis
Das, 1998 [14] 27f Infarction of left middle cerebral artery territory None
Michotte, 1991 [15] 29m Multiple bilateral subcortical lesion None
Figure 3: Histopathological section of skin biopsy. Nonnecrotizing
granuloma with several multinucleated giant cells and epitheliod
histiocytes can be seen. Hematoxylin-eosin ×250.
thepropensityofbasilarinﬂammation[10,19].Tothebestof
ourknowledge,ourreportistheﬁrstcaseofneurosarcoidosis
with a brainstem infarction in the medulla oblongata.
Ocular sarcoidosis is not rare in Japan, and it has been
found that sarcoidosis responds well to steroid therapy. But
10% of ocular sarcoidosis required periocular corticosteroids
to treat the uveitis, and 13% of ocular sarcoidosis required
systemic treatment for both the ocular and systemic disease
[19]. In addition, 8% of patients required immunosup-
pressive therapy because steroids alone did not control the
inﬂammation or the dose required to prevent a relapse of
uveitis was too high [19]. Poor visual outcome ranged from
9% to 66% [19, 20].
The management of resistant uveitis associated with
sarcoidosis is a serious therapeutic problem. The toxicity
from steroids such as osteoporosis, femur head necrosis,
infection,steroidgenicdiabetes,corticosteroid-inducedglau-
coma, and steroid-induced psychosis is diﬃcult to control.
This is why clinicians resist the use of high-dose steroids for
longperiods.Thus,itisimportanttoknowthatsteroid-pulse
therapy is eﬀective in treating the ocular inﬂammation due
to sarcoidosis. Because steroid-pulse therapy has fewer side-
eﬀect, we recommend steroid pulse therapy for ocular and
CNS sarcoidosis.
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